Hello readers! Today’s post focuses on a topic we’ve touched on a few times in the past – Medicaid drug formularies.
Back in December 2021, the state of Oregon released a draft Medicaid waiver proposal that caught the...more
3/1/2022
/ 1115 Waivers ,
Centers for Medicare & Medicaid Services (CMS) ,
Food and Drug Administration (FDA) ,
Managed Care Contracts ,
MDRP ,
Medicaid ,
Oregon ,
Patients ,
Prescription Drugs ,
Proposed Legislation ,
State and Local Government ,
Waivers
Donald Trump extended two directives restricting the admission of certain immigrants and nonimmigrants to the U.S. Specifically, Presidential Proclamation (PP) 10014 restricting the admission of first-time immigrants and PP...more
1/6/2021
/ Advisory Opinions ,
Compliance ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Enforcement Actions ,
Final Rules ,
Health Care Providers ,
Manufacturers ,
Medicaid ,
OGC ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Section 340B
We are back again with another 340B post. The 340B program has recently been a regular feature on the blog in the context of ongoing litigation discussed here and here. Today, we wanted to provide readers the details of an...more
9/24/2020
/ Covered Entities ,
Drug Pricing ,
GAO ,
HRSA ,
Manufacturers ,
Medicaid ,
New Guidance ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B